{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:20Z","timestamp":1756902140984,"version":"3.44.0"},"reference-count":10,"publisher":"The Pediatric Pharmacy Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>This study evaluated newborn gentamicin serum concentrations after birth and the effects on the newborn after extended interval gentamicin dosing in peripartum mothers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>This was a single-center, retrospective chart review of neonates born to mothers that received peripartum once-daily gentamicin dosing of approximately 5 mg\/kg within 12 hours of delivery. A gentamicin serum concentration was obtained immediately after birth in the newborn. The primary outcome was initial neonatal gentamicin serum concentration after birth. Several secondary outcomes were evaluated including nephrotoxicity and ototoxicity. A subgroup analysis comparing baseline demographics of mother-newborn dyads with birth neonatal serum concentrations of less than 2 mcg\/mL versus 2 mcg\/mL or greater was performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>A total of 32 mother-newborn dyads were included. Newborns had a median gestational age of 39.4 weeks and median birth weight of 3.4 kg. The mean initial gentamicin serum concentration was elevated at 3.1 \u00b1 1.9 mcg\/mL among all newborns. The median maternal dose based on actual body weight in newborns with gentamicin serum concentrations less than 2 mcg\/mL was 3.5 (IQR, 3.3\u20134.8) mg\/kg versus 4.8 (IQR, 4.3\u20135.2) mg\/kg in those that had serum concentrations of 2 mcg\/mL or greater (p = 0.025). All newborn gentamicin serum concentrations were less than 2 mcg\/mL for maternal doses given less than 1 hour prior to delivery (n = 8). There were no significant differences in nephrotoxicity or ototoxicity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Peripartum once daily dosing of gentamicin administered between 1 to 12 hours of birth may lead to clinically significant serum concentrations in newborns.<\/jats:p>\n               <\/jats:sec>","DOI":"10.5863\/1551-6776-28.4.316","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T12:30:51Z","timestamp":1691843451000},"page":"316-322","source":"Crossref","is-referenced-by-count":0,"title":["Neonatal Serum Gentamicin Concentrations and Outcomes Following Maternal Once-Daily Gentamicin Dosing"],"prefix":"10.5863","volume":"28","author":[{"given":"Genene Alexis","family":"Wilson","sequence":"first","affiliation":[{"name":"Department of Pharmacy (GAW), Dell Children\u2019s Medical Center, Austin, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah S.","family":"Bondi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (DSB, PAS, AN, PHB), University of Chicago Medicine Comer Children\u2019s Hospital, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja A.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (DSB, PAS, AN, PHB), University of Chicago Medicine Comer Children\u2019s Hospital, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (DSB, PAS, AN, PHB), University of Chicago Medicine Comer Children\u2019s Hospital, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madan","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (MK), University of Chicago, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Palak H.","family":"Bhagat","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (DSB, PAS, AN, PHB), University of Chicago Medicine Comer Children\u2019s Hospital, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"issue":"4","key":"2023081212302338500_i2331-348X-28-4-316-b1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0002-9378(97)70269-2","article-title":"A randomized, prospective study comparing once-daily gentamicin versus thrice-daily gentamicin in the treatment of puerperal infection","volume":"177","author":"Mitra","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2023081212302338500_i2331-348X-28-4-316-b2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000151106.87930.1a","article-title":"High compared with standard gentamicin dosing for chorioamnionitis: a comparison of maternal and fetal serum drug levels","volume":"105","author":"Locksmith","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2023081212302338500_i2331-348X-28-4-316-b3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/GRF.0b013e31818091cd","article-title":"Once daily dosing of gentamicin in obstetrics and gynecology","volume":"51","author":"Ward","year":"2008","journal-title":"Clin Obstet Gynecol"},{"key":"2023081212302338500_i2331-348X-28-4-316-b4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/AOG.0b013e3181cb5c0e","article-title":"Daily compared with 8-hour gentamicin for the treatment of intrapartum chorioamnionitis: a randomized controlled trial","volume":"115","author":"Lyell","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2023081212302338500_i2331-348X-28-4-316-b5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-3476(72)80470-0","article-title":"Placental transfer of gentamicin","volume":"80","author":"Yoshioka","year":"1972","journal-title":"J Pediatr"},{"issue":"3","key":"2023081212302338500_i2331-348X-28-4-316-b6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00669729","article-title":"Transfer of gentamicin to the foetus and the amniotic fluid during a steady state in the mother","volume":"217","author":"Daubenfeld","year":"1974","journal-title":"Arch Gynakol"},{"issue":"2","key":"2023081212302338500_i2331-348X-28-4-316-b7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1203\/00006450-197502000-00009","article-title":"Placental transfer and fetal urinary excretion of gentamicin during constant rate maternal infusion","volume":"9","author":"Kauffman","year":"1975","journal-title":"Pediatr Res"},{"issue":"1","key":"2023081212302338500_i2331-348X-28-4-316-b8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/jpme.1980.8.1.13","article-title":"Ampicillin and gentamicin in the treatment of fetal intrauterine infections","volume":"8","author":"Creatsas","year":"1980","journal-title":"J Perinat Med"},{"issue":"9","key":"2023081212302338500_i2331-348X-28-4-316-b9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/00006454-200009000-00018","article-title":"Gentamicin serum concentrations in neonates born to gentamicin-treated mothers","volume":"19","author":"Regev","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"suppl","key":"2023081212302338500_i2331-348X-28-4-316-b10","first-page":"1","article-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Inter"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/28\/4\/316\/3248440\/i2331-348x-28-4-316.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/28\/4\/316\/3248440\/i2331-348x-28-4-316.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:38:30Z","timestamp":1738780710000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/28\/4\/article-p316.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":10,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8,9]]},"published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-28.4.316","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"type":"electronic","value":"2331-348X"},{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}